CRF® Unveils 2024 SET-10: Recognizing Global Scientific Excellence at TCT®
The Premier Ranking of Global Academic and Medical Institutions Leading the Way in Interventional Cardiovascular Medicine, Based on Academic Contributions at TCT® 2024
Background and Overview
The Cardiovascular Research Foundation (CRF®) proudly announces the 2024 SET-10 (Scientific Excellence Top 10), honoring the institutions making the most significant contributions to interventional cardiovascular research at this year’s Transcatheter Cardiovascular Therapeutics® (TCT®) conference. This global ranking sets a benchmark for academic and medical institutions striving to revolutionize heart care.
TCT®: Pioneering the Future of Cardiovascular Medicine
Since its inception in 1988, TCT® has evolved into the leading global event in interventional cardiovascular medicine, attracting more than 10,000 participants annually. Each year, TCT® gathers top researchers and clinicians to present groundbreaking studies that shape clinical practice and improve patient outcomes. In line with this mission, the SET-10 for 2024 celebrates the institutions making the most significant academic contributions at TCT® 2024.
Celebrating Excellence: The SET-10 Rankings
The 2024 SET-10 rankings honor the dedication of researchers and clinicians whose work was selected for presentation at TCT® 2024. These rankings are based on scientific submissions, ranging from basic science to clinical studies, all vying for the opportunity to be presented on the TCT® global stage. A total of 29 institutions earned a spot in this year’s rankings, spanning categories that showcase their influence within the United States, internationally, and across specific research areas.
CRF® SET-10 Ranking Categories
- CRF® SET-10: Global
- CRF® SET-10: United States
- CRF® SET-10: Non-U.S.
- CRF® SET-10: Coronary
- CRF® SET-10: Structural
- CRF® SET-10: Late-Breaking Clinical Research
Rankings are determined based on the cumulative scores of submissions received for TCT® 2024, offering recognition to institutions that excel in advancing interventional cardiovascular research.
Methodology
A total of 1,320 abstracts were submitted for presentation at TCT® 2024, and 1,020 were accepted.
Of the total, 596 submissions were from the United States, and 724 were from outside the U.S. (non-U.S.), with 456 and 564 accepted, respectively.
Submissions included 401 in the structural category, with 310 of those accepted, and 449 in the coronary category, with 332 accepted.
Each of these submissions underwent rigorous evaluation by an average of 9.8 expert reviewers, who assessed scientific merit and impact using a scale of 1 to 10 across three specific parameters.
Among the submissions, 120 were classified as late-breaking research, reviewed by a median of 18.7 expert reviewers per submission. Ultimately, 71 were accepted for presentation, including 28 as late-breaking clinical trials or clinical science presentations, either independently or in combination with other submissions.
The analysis encompassed all institutions that submitted abstracts or late-breaking research. A score was assigned to each institution based on the affiliations of the first and last authors. If the first and last authors were affiliated with the same institution, the score was counted only once for that institution. Notably, submissions from the Cardiovascular Research Foundation® were excluded from this analysis.
Rankings were determined using a new statistical formula that accounted for all scores from scientific submissions, with an average score of ≥7.0. The formula took into consideration average scores (55% weight) and the number (quantity) of accepted submissions (45% weight). The late-breaking clinical trial rankings include the analysis of all late-breaking clinical trials, late-breaking clinical science, and featured clinical science accepted at the meeting. The formula included average scores (50% weight), number (quantity) of accepted submissions (40% weight), and a 10% bonus (weight) if they were presented as either a late-breaking clinical trial or late-breaking clinical science.
Results
Global Ranking |
||||
|---|---|---|---|---|
Rank |
Institution |
City |
Country |
|
1 |
Asan Medical Center, University of Ulsan College of Medicine Seoul |
Seoul |
South Korea |
|
2 |
Mount Sinai Hospital, Icahn School of Medicine |
New York, New York |
USA |
|
3 |
Mayo Clinic, Rochester |
Rochester, Minnesota |
USA |
|
4 |
Nanjing First Hospital, Nanjing Medical University |
Nanjing |
China |
|
5 |
Henry Ford Health System |
Detroit, Michigan |
USA |
|
6 |
Zhongshan Hospital, Fudan University, Shanghai |
Shanghai |
China |
|
7 |
Seoul National University Hospital |
Seoul |
South Korea |
|
8 |
Yale University School of Medicine, Yale New Haven Hospital |
New Haven, Connecticut |
USA |
|
9 |
New York-Presbyterian / Columbia University Irving Medical Center |
New York, New York |
USA |
|
10 |
Beth Israel Deaconess Medical Center, Harvard Medical School |
Boston, Massachusetts |
USA |
|
United States Ranking |
||||
|---|---|---|---|---|
Rank |
Institution |
City |
Country |
|
1 |
Mount Sinai Hospital, Icahn School of Medicine |
New York, New York |
USA |
|
2 |
Mayo Clinic, Rochester |
Rochester, Minnesota |
USA |
|
3 |
Henry Ford Health System |
Detroit, Michigan |
USA |
|
4 |
Yale University School of Medicine, Yale New Haven Hospital |
New Haven, Connecticut |
USA |
|
5 |
New York-Presbyterian / Columbia University Irving Medical Center |
New York, New York |
USA |
|
6 |
Beth Israel Deaconess Medical Center, Harvard Medical School |
Boston, Massachusetts |
USA |
|
7 |
Cedars-Sinai Medical Center |
Los Angeles, California |
USA |
|
8 |
Minneapolis Heart Institute |
Minneapolis, Minnesota |
USA |
|
9 |
Tufts Medical Center |
Boston, Massachusetts |
USA |
|
10 |
Houston Methodist DeBakey Heart and Vascular Center |
Houston, Texas |
USA |
|
Non-U.S. Ranking |
||||
|---|---|---|---|---|
Rank |
Institution |
City |
Country |
|
1 |
Asan Medical Center, University of Ulsan College of Medicine, Seoul |
Seoul |
South Korea |
|
2 |
Nanjing First Hospital, Nanjing Medical University |
Nanjing |
China |
|
3 |
Zhongshan Hospital, Fudan University, Shanghai |
Shanghai |
China |
|
4 |
Seoul National University Hospital |
Seoul |
South Korea |
|
5 |
Odense University Hospital |
Odense |
Denmark |
|
6 |
Amsterdam University Medical Center / VUMC / AMC |
Amsterdam |
Netherlands |
|
7 |
Cardiovascular Center OLV-Aalst |
Aalst |
Belgium |
|
8 |
National University of Ireland Galway |
Galway |
Ireland |
|
9 |
Korea University Guro Hospital |
Seoul |
South Korea |
|
10 |
University Hospital Rigshospitalet |
Copenhagen |
Denmark |
|
Coronary Ranking |
||||
|---|---|---|---|---|
Rank |
Institution |
City |
Country |
|
1 |
Mount Sinai Hospital, Icahn School of Medicine |
New York, New York |
USA |
|
2 |
Nanjing First Hospital, Nanjing Medical University |
Nanjing |
Nanjing |
|
3 |
Odense University Hospital |
Odense |
Denmark |
|
4 |
Tufts Medical Center |
Boston, Massachusetts |
USA |
|
5 |
New York-Presbyterian / Columbia University Irving Medical Center |
New York, New York |
USA |
|
6 |
Zhongshan Hospital, Fudan University, Shanghai |
Shanghai |
China |
|
7 |
Henry Ford Health System |
Detroit, Michigan |
USA |
|
8 |
Amsterdam University Medical Center / VUMC / AMC |
Amsterdam |
Netherlands |
|
9 |
University Hospital Leuven |
Leuven |
Belgium |
|
10 |
University Hospital Rigshospitalet |
Copenhagen |
Denmark |
|
Structural Ranking |
||||
|---|---|---|---|---|
Rank |
Institution |
City |
Country |
|
1 |
Henry Ford Health System |
Detroit, Michigan |
USA |
|
2 |
Houston Methodist DeBakey Heart and Vascular Center |
Houston, Texas |
USA |
|
3 |
Georgia Institute of Technology, Emory University |
Atlanta, Georgia |
USA |
|
4 |
Mayo Clinic, Rochester |
Rochester, Minnesota |
USA |
|
5 |
Yale University School of Medicine, Yale New Haven Hospital |
New Haven, Connecticut |
USA |
|
6 |
Cedars-Sinai Medical Center |
Los Angeles, California |
USA |
|
7 |
Zhongshan Hospital, Fudan University, Shanghai |
Shanghai |
China |
|
8 |
St Paul's Hospital, Vancouver |
Vancouver, British Columbia |
Canada |
|
9 |
Minneapolis Heart Institute |
Minneapolis, Minnesota |
USA |
|
10 |
Georgetown University, Medstar Washington Hospital Center |
Washington, District of Columbia |
USA |
|
Late-Breaking Clinical Research Ranking |
||||
|---|---|---|---|---|
Rank | Institution | City | Country | |
1 | New York-Presbyterian / Columbia University Irving Medical Center | New York, New York | USA | |
2 | Mount Sinai Hospital, Icahn School of Medicine | New York, New York | USA | |
3 | Cedars-Sinai Medical Center | Los Angeles, California | USA | |
4 | Asan Medical Center, University of Ulsan College of Medicine, Seoul | Seoul | South Korea | |
5 | Gagnon Cardiovascular Institute, Morristown Medical Center | Morristown, New Jersey | USA | |
6 | Piedmont Heart Institute | Atlanta, Georgia | USA | |
7 | Thoraxcenter, Erasmus University Medical Center, Rotterdam | Rotterdam | Netherlands | |
8 | Bern University Hospital | Bern | Switzerland | |
9 | Beth Israel Deaconess Medical Center, Harvard Medical School | Boston, Massachusetts | USA | |
10 | Population Health Research Institute, McMaster University and Hamilton Health Sciences | Hamilton, Ontario | Canada | |